Amphastar Pharmaceuticals, Inc. · NASDAQ:AMPH
Peters William J sold 28,631 Amphastar Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 4 to Nov 5, 2026 · Filed Nov 6, 2026
From Nov 4 to Nov 5, 2026, Peters William J (Director, CFO, EVP & TREASURER) sold 28,631 Amphastar Pharmaceuticals, Inc. shares at an average US$28.45 for US$815K under a trading plan, leaving 167,076 shares. Filed Nov 6, 2026 (Form 4).
- Sold
- 28,631 shares
- Price
- US$28.45 average (US$28.03 to US$28.99)
- Value
- US$815K
- Holding after
- 167,076 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CFO, EVP & TREASURER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | Option exercise | 16,000 | US$13.03 | 184,707 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 16,000 | US$28.03 | 168,707 | Direct |
| Nov 5, 2026 | Common Stock | Option exercise | 11,000 | US$17.99 | 179,707 | Direct |
| Nov 5, 2026 | Common Stock | Sale | 12,631 | US$28.99 | 167,076 | Direct |
Source
Download original · View original at SEC
Related
- Amphastar Pharmaceuticals, Inc.
- Peters William J
- Amphastar Pharmaceuticals, Inc. shareholders
- Form 4 · Peters William J · Nov 18, 2026
- Form 4 · Peters William J · Sep 23, 2026
- Form 4 · Peters William J · Aug 11, 2026
- Form 4 · Zhou Rong · Sep 17, 2026
- Form 4 · Zhou Rong · Sep 3, 2026
- Form 4 · Prins Richard K · Aug 12, 2026
- Schedule 13G · Dimensional Fund Advisors LP · Jul 14, 2026
- Form 4 · Pierce Anthony T · Jul 13, 2026